Pharmacogenomics is an advanced field of biomedical science that studies how a person’s genetic makeup affects their response to drugs. By analyzing genetic variations, pharmacogenomics helps predict how patients metabolize medications, which treatments will be most effective, and what potential side effects may arise. As precision medicine becomes central to modern healthcare,...
Pharmacogenomics Market to Reach USD 9.63 Billion by 2034, Growing at 8.16% CAGR: Polaris Market Research
According to a new report by Polaris Market Research, the global Pharmacogenomics market was valued at USD 4.75 billion in 2025 and is projected to reach USD 9.63 billion by 2034, expanding at a CAGR of 8.16% over the forecast period. The market stood at an estimated USD 5.13 billion in...
Key Drivers Impacting Executive Summary Pharmacogenomics Market Size and Share
The global pharmacogenomics market size was valued at USD 9.62 billion in 2024 and is expected to reach USD 21.87 billion by 2032, at a CAGR of 10.8% during the forecast period
The credible Pharmacogenomics Marketreport comprises of various segments linked to Pharmacogenomics...
Global Demand Outlook for Executive Summary Pharmacogenomics Market Size and Share
The global pharmacogenomics market size was valued at USD 9.62 billion in 2024 and is expected to reach USD 21.87 billion by 2032, at a CAGR of 10.8% during the forecast period
For a constantly increasing business growth and maximum return on investment (ROI), market research report...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)